Crinetics Pharmaceuticals Insider Trades

CRNX

Track insider trading activity from Crinetics Pharmaceuticals executives and directors. See which insiders are buying and selling CRNX stock.

Trades Last 12 Months

CRNX Price

All Insider Trades for Crinetics Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nichols Weston Director
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Deardorf Caren Director
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Wierenga Wendell Director
Holding Value $10.2M 122,071 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Fust Matthew K Director
Holding Value $2.41M 28,761 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Okey Stephanie Director
Holding Value $1.03M 12,325 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.71
Struthers Richard Scott President & CEO
Holding Value $52.5M 626,978 shares
Last Trade
May 29, 2026 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$22.6M 635,500 shares
$35.55
$83.71
Knight Jeff E. Chief Dev. & Operating Officer
Holding Value $8.81M 105,289 shares
Last Trade
Apr 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.42M 85,163 shares
$40.10
$83.71
Betz Stephen F. Chief Scientific Officer
Holding Value $11.8M 141,342 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$397k 10,612 shares
$37.37
$83.71
Schilke Tobin Chief Financial Officer
Holding Value $6.54M 78,121 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$266k 6,713 shares
$39.67
$83.71
Kalofonos Isabel Chief Commercial Officer
Holding Value $4.6M 55,000 shares
Last Trade
Feb 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.9M 89,000 shares
$43.79
$83.71
Pizzuti Dana Chief Med And Dev Officer
Holding Value $5.78M 69,042 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 5,000 shares
$45.25
$83.71
Wierenga Wendall Director
Holding Value $9.72M 116,146 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$83.71
Hassard James Chief Commercial Officer
Holding Value $2.45M 29,259 shares
Last Trade
Jul 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$661k 15,000 shares
$44.08
$83.71
Krasner Alan Seth Chief Medical Officer
Holding Value $12.8M 153,473 shares
Last Trade
Oct 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$201k 7,000 shares
$28.69
$83.71
Edelman Joseph Director
Holding Value $445M 5,321,032 shares
Last Trade
Apr 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.5M 157,515 shares
$22.22
$83.71
Holding Value $445M 5,321,032 shares
Last Trade
Apr 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.5M 157,515 shares
$22.22
$83.71
Madan Ajay Chief Development Officer
Holding Value $14.8M 176,995 shares
Last Trade
Mar 01, 2022 Purchase (Open Market)Shares sold on the open market or in a private sale.
$179k 9,000 shares
$19.88
$83.71
Kaldor Stephen W Director
Holding Value $1.05M 12,500 shares
Last Trade
Jun 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$290k 12,500 shares
$23.23
$83.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up